Results 11 to 20 of about 7,032 (221)

Recurrent Steroid-Responsive Exophthalmos as a Paraneoplastic Manifestation of Esophageal Adenocarcinoma

open access: yesCase Reports in Oncological Medicine
Exophthalmos is most often associated with autoimmune thyroid disease, particularly Graves disease. Paraneoplastic syndromes rarely manifest as orbital inflammation, and only a few cases have been described in association with solid tumors.
Yara E. Tovar, Ahmed G. Elsayed
doaj   +2 more sources

Modified Deep Lateral Wall Decompression Surgery in the Treatment of Thyroid‐Associated Ophthalmopathy: A Retrospective Evaluation

open access: yesEye & ENT Research
Background Thyroid‐associated ophthalmopathy (TAO) may lead to severe exophthalmos and dysthyroid optic neuropathy (DON), which can threaten visual function.
Shuo Wu   +4 more
doaj   +2 more sources

Teprotumumab for Thyroid Eye Disease: Efficacy and Impact on Orbital Decompression Utilization. [PDF]

open access: yesLaryngoscope Investig Otolaryngol
Teprotumumab has been proven effective in thyroid eye disease and associated exophthalmos management. Since its FDA approval in 2020, teprotumumab therapy has been a popular choice for managing exophthalmos which has resulted in decreased utilization of orbital decompression surgery, from 36.8% between 2015 and 2020 to 11.1% TED patients between 2020 ...
Kumar N   +5 more
europepmc   +2 more sources

SEARCH FOR TARGET TISSUE IN THE EYE ORBIT FOR AUTOIMMUNE AGGRESSION OF THYROID ANTIBODIES IN ENDOCRINE OPHTHALMOPATHY

open access: yesМедицинская иммунология, 2017
We searched for a possible target tissue in eye orbit for thyroid autoantibodies in endocrine ophthalmopathy (Graves’ disease), using correlation analysis method. We examined a group of 139 patients (278 eye orbits) with thyroid-associated ophthalmopathy
V. G. Likhvantseva   +4 more
doaj   +1 more source

Graves' ophthalmopathy [PDF]

open access: yes, 2009
A 40-year-old woman who recently received a diagnosis of Graves' disease comes for a follow-up visit. She has been taking methimazole, at a dose of 10 mg daily, and is now euthyroid, but for the past 3 months, she has had bothersome eye symptoms ...
Bartalena, Luigi   +1 more
core   +1 more source

Dilated cardiomyopathy in hyperthyroidism can be reversed with treatment

open access: yesHeart Views, 2023
The authors present a case of a 54-year-old male patient with a history of shortness of breath and orthopnea. The echocardiogram showed an ejection fraction (EF) of 35%–40%.
Lama Alasmari   +3 more
doaj   +1 more source

Exophthalmos and multinodular goitre, an unusual combination

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2019
Multinodular goitre is not associated with eye disease, unless in a rare case of Marine–Lenhart syndrome where it coexists with Grave’s disease. Therefore, other causes of exophthalmos need to be ruled out when the eye disease is seen in a patient with
Kingsley Okolie   +3 more
doaj   +1 more source

Effect of vitamin D3 in treating hyperthyroidism in patients with graves’ disease

open access: yesThe Egyptian Journal of Internal Medicine, 2017
Background Graves’ disease (GD) is an autoimmune disease characterized by hyperthyroidism secondary to circulating autoantibodies. Multiple factors contributed to its etiology, including genetic and environmental factors.
Nermin A Sheriba   +6 more
doaj   +1 more source

Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications [PDF]

open access: yes, 2019
Background: Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Diabetes mellitus (DM) has been reported to be a risk factor in patients with GO.
Biondi, B   +5 more
core   +2 more sources

Hypothyroidism conversion to hyperthyroidism: it's never too late. [PDF]

open access: yes, 2018
Primary hypothyroidism is a common endocrine condition, most commonly caused by autoimmune thyroiditis (Hashimoto's disease) while Graves' disease is the most common cause of hyperthyroidism.
Ahmad, E   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy